Phyxius Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Search jobs 07-Apr-2021 Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that Ronald R. Blanck, D.O., Gregory Pepin and Chris A. Rallis ...

Press release content from Business Wire. The AP news staff was not involved in its creation. Tenax Therapeutics to Present at the H.C. Wainwright Global Life Sciences Virtual Conference March 4, 2021 GMT Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today announced that management will present a company overview and hold virtual investor meetings at the H.C. Wainwright Global Life Sciences Virtual Conference being held March 9-10, 2021. The p...

Published: Mar 02, 2021   New Board appointments strengthen Tenax with world-class expertise in cardiovascular drug development, commercial strategy, and business development New Directors will provide significant guidance as Tenax is poised to advance its two leading drug candidates into late-stage clinical testing Transformational step as Tenax strengthens its positioning as a leading specialty pharmaceutical company focused on cardio-pulmonary therapeutics   a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases ...

Press release content from Business Wire. The AP news staff was not involved in its creation.